These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6579606)

  • 21. Selective antibacterial properties of lysozyme for oral microorganisms.
    Iacono VJ; MacKay BJ; DiRienzo S; Pollock JJ
    Infect Immun; 1980 Aug; 29(2):623-32. PubMed ID: 7216430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysozyme-protease-inorganic monovalent anion lysis of oral bacterial strains in buffers and stimulated whole saliva.
    Pollock JJ; Lotardo S; Gavai R; Grossbard BL
    J Dent Res; 1987 Feb; 66(2):467-74. PubMed ID: 3114343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of lysozyme with a surface protein antigen of Streptococcus mutans.
    Senpuku H; Kato H; Todoroki M; Hanada N; Nisizawa T
    FEMS Microbiol Lett; 1996 Jun; 139(2-3):195-201. PubMed ID: 8674988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of salivary lysozyme on glucose incorporation and acid production in Streptococcus mutans.
    Twetman S; Lindqvist L
    Caries Res; 1985; 19(5):414-21. PubMed ID: 3864543
    [No Abstract]   [Full Text] [Related]  

  • 25. Lysozyme activity and L(+)-lactic acid production in saliva in schoolchildren with high Lactobacillus counts.
    Twetman S; Dahllöf G; Wikner S
    Scand J Dent Res; 1987 Apr; 95(2):128-31. PubMed ID: 3470907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary proteins promote proteolytic activity in Streptococcus mitis biovar 2 and Streptococcus mutans.
    Kindblom C; Davies JR; Herzberg MC; Svensäter G; Wickström C
    Mol Oral Microbiol; 2012 Oct; 27(5):362-72. PubMed ID: 22958385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysozyme-mediated de-chaining of Streptococcus mutans and its antibacterial significance in an acidic environment.
    Iacono VJ; Byrnes TP; Crawford IT; Grossbard BL; Pollock JJ; MacKay BJ
    J Dent Res; 1985 Jan; 64(1):48-53. PubMed ID: 3855420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method for the lysis of Gram-positive, asporogenous bacteria with lysozyme.
    Chassy BM; Giuffrida A
    Appl Environ Microbiol; 1980 Jan; 39(1):153-8. PubMed ID: 6986847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of lysozyme in a salt solution on lactate production by Streptococcus mutans].
    Otake J; Tsunosue M; Morikawa M
    Shigaku; 1984 Apr; 71(6):1024-35. PubMed ID: 6591079
    [No Abstract]   [Full Text] [Related]  

  • 30. Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces.
    Park WK; Chung JW; Kim YK; Chung SC; Kho HS
    Arch Oral Biol; 2006 Oct; 51(10):861-9. PubMed ID: 16716246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial mechanisms of lysozyme on Streptococcus mutans.
    Wang YB
    Zhonghua Ya Yi Xue Hui Za Zhi; 1990 Sep; 9(3):87-97. PubMed ID: 2135996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449.
    Wang YB; Germaine GR
    Infect Immun; 1991 Feb; 59(2):638-44. PubMed ID: 1987080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial effects of saliva substitutes containing lysozyme or lactoferrin against Streptococcus mutans.
    Tonguc Altin K; Topcuoglu N; Duman G; Unsal M; Celik A; Selvi Kuvvetli S; Kasikci E; Sahin F; Kulekci G
    Arch Oral Biol; 2021 Sep; 129():105183. PubMed ID: 34091207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viability of Streptococcus mutans and Streptococcus sobrinus in whole saliva with varying concentrations of indigenous antimicrobial agents.
    Lenander-Lumikari M; Tenovuo J; Emilson CG; Vilja P
    Caries Res; 1992; 26(5):371-8. PubMed ID: 1334804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protoplast and cytoplasmic membrane preparations from Streptococcus sanguis and Streptococcus mutans.
    Schöller M; Klein JP; Sommer P; Frank R
    J Gen Microbiol; 1983 Oct; 129(10):3271-9. PubMed ID: 6361217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinity chromatography of human saliva lysozyme and effect of pH and ionic strength on lytic activity.
    Vasstrand EN; Jensen HB
    Scand J Dent Res; 1980 Jun; 88(3):219-28. PubMed ID: 6932088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriolytic enzyme induced from pyocinogenic Pseudomonas aeruginosa. Purification and characterization of PR1-lysozyme.
    Ochi N; Azegami M; Ishii SI
    J Biochem; 1978 Mar; 83(3):727-36. PubMed ID: 25269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry.
    Tenovuo J; Lumikari M; Soukka T
    Proc Finn Dent Soc; 1991; 87(2):197-208. PubMed ID: 1896432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of Streptococcus sanguis by an extracellular enzyme from the bacterium Streptococcus mutans from human dental plaque.
    Baba H
    Arch Oral Biol; 1986; 31(12):849-53. PubMed ID: 3479961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial systems of human whole saliva in relation to dental caries, cariogenic bacteria, and gingival inflammation in young adults.
    Gråhn E; Tenovuo J; Lehtonen OP; Eerola E; Vilja P
    Acta Odontol Scand; 1988 Apr; 46(2):67-74. PubMed ID: 3164564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.